A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT03285763 · COMPLETED
Trial details
- NCT number
- NCT03285763
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-25
- Primary completion
- 2022-04-07
- Enrollment
- 619
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.